Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 17 | $820,321 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 07 Feb 2024 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Feb 2024 | Sale | 4,600 | 17.4455 | 80,249 | D |
| 08 Jan 2024 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Jan 2024 | Sale | 2,474 | 19.5718 | 48,421 | D |
| 08 Jan 2024 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Jan 2024 | Sale | 2,126 | 18.6713 | 39,695 | D |
| 07 Dec 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Dec 2023 | Sale | 4,600 | 16.3034 | 74,996 | D |
| 27 Nov 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 22 Nov 2023 | Sale | 13,800 | 15 | 207,000 | D |
| 07 Jul 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Jul 2023 | Sale | 219 | 17.8686 | 3,913 | D |
| 07 Jul 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Jul 2023 | Sale | 2,031 | 17.2337 | 35,002 | D |
| 07 Jun 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Jun 2023 | Sale | 2,250 | 16.256 | 36,576 | D |
| 09 May 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 May 2023 | Sale | 205 | 21.6348 | 4,435 | D |
| 09 May 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 May 2023 | Sale | 2,045 | 20.793 | 42,522 | D |
| 07 Apr 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Apr 2023 | Sale | 535 | 19.1056 | 10,221 | D |
| 07 Apr 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Apr 2023 | Sale | 1,715 | 17.913 | 30,721 | D |
| 08 Mar 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 06 Mar 2023 | Sale | 45 | 24.924 | 1,122 | D |
| 08 Mar 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 06 Mar 2023 | Sale | 2,205 | 23.727 | 52,318 | D |
| 08 Feb 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 06 Feb 2023 | Sale | 2,250 | 24.272 | 54,612 | D |
| 09 Jan 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Jan 2023 | Sale | 2,250 | 26.402 | 59,404 | D |
| 07 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Dec 2022 | Sale | 2,250 | 17.384 | 39,114 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)